SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-23-087929
Filing Date
2023-08-04
Accepted
2023-08-04 17:30:29
Documents
12
Period of Report
2023-02-16
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 8-K/A tm2322865d1_8ka.htm   iXBRL 8-K/A 23841
  Complete submission text file 0001104659-23-087929.txt   191677

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cbdy-20230216.xsd EX-101.SCH 3301
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbdy-20230216_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbdy-20230216_pre.xml EX-101.PRE 22371
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2322865d1_8ka_htm.xml XML 3200
Mailing Address 55 ADMINISTRATION ROAD, UNIT 13 VAUGHAN A6 L4K-4G9
Business Address 55 ADMINISTRATION ROAD, UNIT 13 VAUGHAN A6 L4K-4G9 905-541-3833
Target Group Inc. (Filer) CIK: 0001586554 (see all company filings)

IRS No.: 463610035 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-55066 | Film No.: 231145081
SIC: 2833 Medicinal Chemicals & Botanical Products